A detailed history of Skyline Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Skyline Advisors, Inc. holds 2,623 shares of JNJ stock, worth $408,610. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,623
Previous 2,590 1.27%
Holding current value
$408,610
Previous $379 Million 12.32%
% of portfolio
0.18%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$145.48 - $167.38 $4,800 - $5,523
33 Added 1.27%
2,623 $425 Million
Q2 2024

Jul 30, 2024

BUY
$144.38 - $157.78 $16,170 - $17,671
112 Added 4.52%
2,590 $379 Million
Q1 2024

Apr 17, 2024

BUY
$155.22 - $162.74 $12,883 - $13,507
83 Added 3.47%
2,478 $392 Million
Q4 2023

Mar 15, 2024

BUY
$145.6 - $158.88 $348,712 - $380,517
2,395 New
2,395 $375 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Skyline Advisors, Inc. Portfolio

Follow Skyline Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skyline Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skyline Advisors, Inc. with notifications on news.